Nerea Zabaleta Lasarte, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dependovirus | 6 | 2021 | 706 | 1.020 |
Why?
|
Liver Diseases | 2 | 2022 | 1252 | 0.840 |
Why?
|
Hemophilia B | 1 | 2019 | 81 | 0.680 |
Why?
|
Hyperoxaluria, Primary | 1 | 2018 | 22 | 0.670 |
Why?
|
Oxalates | 1 | 2018 | 105 | 0.650 |
Why?
|
Alcohol Oxidoreductases | 1 | 2018 | 170 | 0.630 |
Why?
|
Transduction, Genetic | 2 | 2017 | 913 | 0.590 |
Why?
|
Genetic Vectors | 5 | 2020 | 3420 | 0.570 |
Why?
|
Hemophilia A | 1 | 2019 | 351 | 0.550 |
Why?
|
Antibodies, Viral | 3 | 2021 | 3164 | 0.460 |
Why?
|
Metabolic Diseases | 1 | 2019 | 657 | 0.440 |
Why?
|
Antibodies, Neutralizing | 2 | 2021 | 1970 | 0.420 |
Why?
|
Gene Transfer Techniques | 4 | 2019 | 1224 | 0.370 |
Why?
|
Liver | 4 | 2019 | 7470 | 0.320 |
Why?
|
Macaca fascicularis | 2 | 2021 | 908 | 0.300 |
Why?
|
Hepatocytes | 2 | 2019 | 1209 | 0.200 |
Why?
|
Receptors, Adrenergic, alpha-1 | 1 | 2020 | 48 | 0.190 |
Why?
|
Transgenes | 2 | 2021 | 1009 | 0.180 |
Why?
|
Immunosorbent Techniques | 1 | 2019 | 184 | 0.180 |
Why?
|
Nephrocalcinosis | 1 | 2018 | 48 | 0.170 |
Why?
|
Alkaline Phosphatase | 2 | 2019 | 865 | 0.150 |
Why?
|
Hepatitis B virus | 1 | 2020 | 513 | 0.150 |
Why?
|
Injections, Intra-Arterial | 1 | 2017 | 193 | 0.150 |
Why?
|
Lentivirus | 1 | 2019 | 501 | 0.140 |
Why?
|
Conserved Sequence | 1 | 2019 | 1202 | 0.140 |
Why?
|
Hepatitis B | 1 | 2020 | 695 | 0.130 |
Why?
|
Macaca mulatta | 1 | 2021 | 2378 | 0.130 |
Why?
|
Injections, Intravenous | 1 | 2017 | 1420 | 0.120 |
Why?
|
Immunologic Memory | 1 | 2021 | 1348 | 0.120 |
Why?
|
Animals | 9 | 2022 | 168561 | 0.110 |
Why?
|
Viral Load | 1 | 2021 | 3292 | 0.110 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 6382 | 0.100 |
Why?
|
Dendritic Cells | 1 | 2020 | 2723 | 0.090 |
Why?
|
HEK293 Cells | 1 | 2018 | 4200 | 0.090 |
Why?
|
Vaccination | 1 | 2021 | 3256 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2019 | 2117 | 0.080 |
Why?
|
RNA, Messenger | 1 | 2022 | 13029 | 0.070 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 21821 | 0.070 |
Why?
|
Mice | 4 | 2021 | 81045 | 0.070 |
Why?
|
Primates | 2 | 2019 | 543 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5867 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10163 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2020 | 7873 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7901 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18006 | 0.060 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2020 | 107 | 0.050 |
Why?
|
Factor IX | 1 | 2019 | 77 | 0.040 |
Why?
|
Golgi Apparatus | 1 | 2019 | 410 | 0.040 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2019 | 474 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2019 | 936 | 0.040 |
Why?
|
Interferon Type I | 1 | 2020 | 542 | 0.040 |
Why?
|
Immunomodulation | 1 | 2020 | 540 | 0.040 |
Why?
|
Adenoviridae | 1 | 2020 | 1096 | 0.040 |
Why?
|
Capsid Proteins | 1 | 2019 | 479 | 0.030 |
Why?
|
Genome, Viral | 1 | 2019 | 667 | 0.030 |
Why?
|
Humans | 7 | 2021 | 742088 | 0.030 |
Why?
|
Cross Reactions | 1 | 2017 | 841 | 0.030 |
Why?
|
Male | 3 | 2021 | 349538 | 0.030 |
Why?
|
Genetic Engineering | 1 | 2019 | 952 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2017 | 2335 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2017 | 596 | 0.030 |
Why?
|
Virus Replication | 1 | 2020 | 2531 | 0.030 |
Why?
|
Phylogeny | 1 | 2019 | 2797 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2019 | 1937 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 4414 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 2978 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14554 | 0.020 |
Why?
|
Gene Expression | 1 | 2017 | 7790 | 0.010 |
Why?
|
Female | 1 | 2021 | 379592 | 0.010 |
Why?
|